Global Point of Care Diagnostic and Testing Market Research Report 2023
According to QYResearch’s new survey, global Point of Care Diagnostic and Testing market is projected to reach US$ 91310 million in 2029, increasing from US$ 45610 million in 2022, with the CAGR of 10.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Point of Care Diagnostic and Testing market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Point of Care Diagnostic and Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Point of Care Diagnostic and Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- F. Hoffmann-La Roche
- Qiagen
- Danaher
- Becton Dickinson and Company
- Biomerieux
- Siemens Healthcare
- Zoetis
- Abbott
- Bayer
- Johnson and Johnson
- Nova Biomedical
- Trividia Health
- Quidel Corporation
- Trinity Biotech
- Sekisui Diagnostics
- Orasure Technologies
- Nipro
- Spectral Medical
- Device
- Consumables
- Others
- Hospitals
- Clinics
- Home
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Diagnostic and Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Device
1.2.3 Consumables
1.2.4 Others
1.3 Market by Application
1.3.1 Global Point of Care Diagnostic and Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Point of Care Diagnostic and Testing Market Perspective (2018-2029)
2.2 Point of Care Diagnostic and Testing Growth Trends by Region
2.2.1 Global Point of Care Diagnostic and Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Point of Care Diagnostic and Testing Historic Market Size by Region (2018-2023)
2.2.3 Point of Care Diagnostic and Testing Forecasted Market Size by Region (2024-2029)
2.3 Point of Care Diagnostic and Testing Market Dynamics
2.3.1 Point of Care Diagnostic and Testing Industry Trends
2.3.2 Point of Care Diagnostic and Testing Market Drivers
2.3.3 Point of Care Diagnostic and Testing Market Challenges
2.3.4 Point of Care Diagnostic and Testing Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Point of Care Diagnostic and Testing Players by Revenue
3.1.1 Global Top Point of Care Diagnostic and Testing Players by Revenue (2018-2023)
3.1.2 Global Point of Care Diagnostic and Testing Revenue Market Share by Players (2018-2023)
3.2 Global Point of Care Diagnostic and Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care Diagnostic and Testing Revenue
3.4 Global Point of Care Diagnostic and Testing Market Concentration Ratio
3.4.1 Global Point of Care Diagnostic and Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Diagnostic and Testing Revenue in 2022
3.5 Point of Care Diagnostic and Testing Key Players Head office and Area Served
3.6 Key Players Point of Care Diagnostic and Testing Product Solution and Service
3.7 Date of Enter into Point of Care Diagnostic and Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 POINT OF CARE DIAGNOSTIC AND TESTING BREAKDOWN DATA BY TYPE
4.1 Global Point of Care Diagnostic and Testing Historic Market Size by Type (2018-2023)
4.2 Global Point of Care Diagnostic and Testing Forecasted Market Size by Type (2024-2029)
5 POINT OF CARE DIAGNOSTIC AND TESTING BREAKDOWN DATA BY APPLICATION
5.1 Global Point of Care Diagnostic and Testing Historic Market Size by Application (2018-2023)
5.2 Global Point of Care Diagnostic and Testing Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Point of Care Diagnostic and Testing Market Size (2018-2029)
6.2 North America Point of Care Diagnostic and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Point of Care Diagnostic and Testing Market Size by Country (2018-2023)
6.4 North America Point of Care Diagnostic and Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Point of Care Diagnostic and Testing Market Size (2018-2029)
7.2 Europe Point of Care Diagnostic and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Point of Care Diagnostic and Testing Market Size by Country (2018-2023)
7.4 Europe Point of Care Diagnostic and Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Point of Care Diagnostic and Testing Market Size (2018-2029)
8.2 Asia-Pacific Point of Care Diagnostic and Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Point of Care Diagnostic and Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Point of Care Diagnostic and Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Point of Care Diagnostic and Testing Market Size (2018-2029)
9.2 Latin America Point of Care Diagnostic and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Point of Care Diagnostic and Testing Market Size by Country (2018-2023)
9.4 Latin America Point of Care Diagnostic and Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Point of Care Diagnostic and Testing Market Size (2018-2029)
10.2 Middle East & Africa Point of Care Diagnostic and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Point of Care Diagnostic and Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Point of Care Diagnostic and Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Detail
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Point of Care Diagnostic and Testing Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Detail
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Point of Care Diagnostic and Testing Introduction
11.2.4 Qiagen Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.2.5 Qiagen Recent Development
11.3 Danaher
11.3.1 Danaher Company Detail
11.3.2 Danaher Business Overview
11.3.3 Danaher Point of Care Diagnostic and Testing Introduction
11.3.4 Danaher Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.3.5 Danaher Recent Development
11.4 Becton Dickinson and Company
11.4.1 Becton Dickinson and Company Company Detail
11.4.2 Becton Dickinson and Company Business Overview
11.4.3 Becton Dickinson and Company Point of Care Diagnostic and Testing Introduction
11.4.4 Becton Dickinson and Company Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.4.5 Becton Dickinson and Company Recent Development
11.5 Biomerieux
11.5.1 Biomerieux Company Detail
11.5.2 Biomerieux Business Overview
11.5.3 Biomerieux Point of Care Diagnostic and Testing Introduction
11.5.4 Biomerieux Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.5.5 Biomerieux Recent Development
11.6 Siemens Healthcare
11.6.1 Siemens Healthcare Company Detail
11.6.2 Siemens Healthcare Business Overview
11.6.3 Siemens Healthcare Point of Care Diagnostic and Testing Introduction
11.6.4 Siemens Healthcare Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.6.5 Siemens Healthcare Recent Development
11.7 Zoetis
11.7.1 Zoetis Company Detail
11.7.2 Zoetis Business Overview
11.7.3 Zoetis Point of Care Diagnostic and Testing Introduction
11.7.4 Zoetis Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.7.5 Zoetis Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Point of Care Diagnostic and Testing Introduction
11.8.4 Abbott Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.8.5 Abbott Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Point of Care Diagnostic and Testing Introduction
11.9.4 Bayer Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.9.5 Bayer Recent Development
11.10 Johnson and Johnson
11.10.1 Johnson and Johnson Company Detail
11.10.2 Johnson and Johnson Business Overview
11.10.3 Johnson and Johnson Point of Care Diagnostic and Testing Introduction
11.10.4 Johnson and Johnson Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.10.5 Johnson and Johnson Recent Development
11.11 Nova Biomedical
11.11.1 Nova Biomedical Company Detail
11.11.2 Nova Biomedical Business Overview
11.11.3 Nova Biomedical Point of Care Diagnostic and Testing Introduction
11.11.4 Nova Biomedical Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.11.5 Nova Biomedical Recent Development
11.12 Trividia Health
11.12.1 Trividia Health Company Detail
11.12.2 Trividia Health Business Overview
11.12.3 Trividia Health Point of Care Diagnostic and Testing Introduction
11.12.4 Trividia Health Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.12.5 Trividia Health Recent Development
11.13 Quidel Corporation
11.13.1 Quidel Corporation Company Detail
11.13.2 Quidel Corporation Business Overview
11.13.3 Quidel Corporation Point of Care Diagnostic and Testing Introduction
11.13.4 Quidel Corporation Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.13.5 Quidel Corporation Recent Development
11.14 Trinity Biotech
11.14.1 Trinity Biotech Company Detail
11.14.2 Trinity Biotech Business Overview
11.14.3 Trinity Biotech Point of Care Diagnostic and Testing Introduction
11.14.4 Trinity Biotech Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.14.5 Trinity Biotech Recent Development
11.15 Sekisui Diagnostics
11.15.1 Sekisui Diagnostics Company Detail
11.15.2 Sekisui Diagnostics Business Overview
11.15.3 Sekisui Diagnostics Point of Care Diagnostic and Testing Introduction
11.15.4 Sekisui Diagnostics Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.15.5 Sekisui Diagnostics Recent Development
11.16 Orasure Technologies
11.16.1 Orasure Technologies Company Detail
11.16.2 Orasure Technologies Business Overview
11.16.3 Orasure Technologies Point of Care Diagnostic and Testing Introduction
11.16.4 Orasure Technologies Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.16.5 Orasure Technologies Recent Development
11.17 Nipro
11.17.1 Nipro Company Detail
11.17.2 Nipro Business Overview
11.17.3 Nipro Point of Care Diagnostic and Testing Introduction
11.17.4 Nipro Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.17.5 Nipro Recent Development
11.18 Spectral Medical
11.18.1 Spectral Medical Company Detail
11.18.2 Spectral Medical Business Overview
11.18.3 Spectral Medical Point of Care Diagnostic and Testing Introduction
11.18.4 Spectral Medical Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.18.5 Spectral Medical Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Diagnostic and Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Device
1.2.3 Consumables
1.2.4 Others
1.3 Market by Application
1.3.1 Global Point of Care Diagnostic and Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Point of Care Diagnostic and Testing Market Perspective (2018-2029)
2.2 Point of Care Diagnostic and Testing Growth Trends by Region
2.2.1 Global Point of Care Diagnostic and Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Point of Care Diagnostic and Testing Historic Market Size by Region (2018-2023)
2.2.3 Point of Care Diagnostic and Testing Forecasted Market Size by Region (2024-2029)
2.3 Point of Care Diagnostic and Testing Market Dynamics
2.3.1 Point of Care Diagnostic and Testing Industry Trends
2.3.2 Point of Care Diagnostic and Testing Market Drivers
2.3.3 Point of Care Diagnostic and Testing Market Challenges
2.3.4 Point of Care Diagnostic and Testing Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Point of Care Diagnostic and Testing Players by Revenue
3.1.1 Global Top Point of Care Diagnostic and Testing Players by Revenue (2018-2023)
3.1.2 Global Point of Care Diagnostic and Testing Revenue Market Share by Players (2018-2023)
3.2 Global Point of Care Diagnostic and Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care Diagnostic and Testing Revenue
3.4 Global Point of Care Diagnostic and Testing Market Concentration Ratio
3.4.1 Global Point of Care Diagnostic and Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Diagnostic and Testing Revenue in 2022
3.5 Point of Care Diagnostic and Testing Key Players Head office and Area Served
3.6 Key Players Point of Care Diagnostic and Testing Product Solution and Service
3.7 Date of Enter into Point of Care Diagnostic and Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 POINT OF CARE DIAGNOSTIC AND TESTING BREAKDOWN DATA BY TYPE
4.1 Global Point of Care Diagnostic and Testing Historic Market Size by Type (2018-2023)
4.2 Global Point of Care Diagnostic and Testing Forecasted Market Size by Type (2024-2029)
5 POINT OF CARE DIAGNOSTIC AND TESTING BREAKDOWN DATA BY APPLICATION
5.1 Global Point of Care Diagnostic and Testing Historic Market Size by Application (2018-2023)
5.2 Global Point of Care Diagnostic and Testing Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Point of Care Diagnostic and Testing Market Size (2018-2029)
6.2 North America Point of Care Diagnostic and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Point of Care Diagnostic and Testing Market Size by Country (2018-2023)
6.4 North America Point of Care Diagnostic and Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Point of Care Diagnostic and Testing Market Size (2018-2029)
7.2 Europe Point of Care Diagnostic and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Point of Care Diagnostic and Testing Market Size by Country (2018-2023)
7.4 Europe Point of Care Diagnostic and Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Point of Care Diagnostic and Testing Market Size (2018-2029)
8.2 Asia-Pacific Point of Care Diagnostic and Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Point of Care Diagnostic and Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Point of Care Diagnostic and Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Point of Care Diagnostic and Testing Market Size (2018-2029)
9.2 Latin America Point of Care Diagnostic and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Point of Care Diagnostic and Testing Market Size by Country (2018-2023)
9.4 Latin America Point of Care Diagnostic and Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Point of Care Diagnostic and Testing Market Size (2018-2029)
10.2 Middle East & Africa Point of Care Diagnostic and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Point of Care Diagnostic and Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Point of Care Diagnostic and Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Detail
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Point of Care Diagnostic and Testing Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Detail
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Point of Care Diagnostic and Testing Introduction
11.2.4 Qiagen Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.2.5 Qiagen Recent Development
11.3 Danaher
11.3.1 Danaher Company Detail
11.3.2 Danaher Business Overview
11.3.3 Danaher Point of Care Diagnostic and Testing Introduction
11.3.4 Danaher Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.3.5 Danaher Recent Development
11.4 Becton Dickinson and Company
11.4.1 Becton Dickinson and Company Company Detail
11.4.2 Becton Dickinson and Company Business Overview
11.4.3 Becton Dickinson and Company Point of Care Diagnostic and Testing Introduction
11.4.4 Becton Dickinson and Company Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.4.5 Becton Dickinson and Company Recent Development
11.5 Biomerieux
11.5.1 Biomerieux Company Detail
11.5.2 Biomerieux Business Overview
11.5.3 Biomerieux Point of Care Diagnostic and Testing Introduction
11.5.4 Biomerieux Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.5.5 Biomerieux Recent Development
11.6 Siemens Healthcare
11.6.1 Siemens Healthcare Company Detail
11.6.2 Siemens Healthcare Business Overview
11.6.3 Siemens Healthcare Point of Care Diagnostic and Testing Introduction
11.6.4 Siemens Healthcare Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.6.5 Siemens Healthcare Recent Development
11.7 Zoetis
11.7.1 Zoetis Company Detail
11.7.2 Zoetis Business Overview
11.7.3 Zoetis Point of Care Diagnostic and Testing Introduction
11.7.4 Zoetis Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.7.5 Zoetis Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Point of Care Diagnostic and Testing Introduction
11.8.4 Abbott Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.8.5 Abbott Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Point of Care Diagnostic and Testing Introduction
11.9.4 Bayer Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.9.5 Bayer Recent Development
11.10 Johnson and Johnson
11.10.1 Johnson and Johnson Company Detail
11.10.2 Johnson and Johnson Business Overview
11.10.3 Johnson and Johnson Point of Care Diagnostic and Testing Introduction
11.10.4 Johnson and Johnson Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.10.5 Johnson and Johnson Recent Development
11.11 Nova Biomedical
11.11.1 Nova Biomedical Company Detail
11.11.2 Nova Biomedical Business Overview
11.11.3 Nova Biomedical Point of Care Diagnostic and Testing Introduction
11.11.4 Nova Biomedical Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.11.5 Nova Biomedical Recent Development
11.12 Trividia Health
11.12.1 Trividia Health Company Detail
11.12.2 Trividia Health Business Overview
11.12.3 Trividia Health Point of Care Diagnostic and Testing Introduction
11.12.4 Trividia Health Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.12.5 Trividia Health Recent Development
11.13 Quidel Corporation
11.13.1 Quidel Corporation Company Detail
11.13.2 Quidel Corporation Business Overview
11.13.3 Quidel Corporation Point of Care Diagnostic and Testing Introduction
11.13.4 Quidel Corporation Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.13.5 Quidel Corporation Recent Development
11.14 Trinity Biotech
11.14.1 Trinity Biotech Company Detail
11.14.2 Trinity Biotech Business Overview
11.14.3 Trinity Biotech Point of Care Diagnostic and Testing Introduction
11.14.4 Trinity Biotech Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.14.5 Trinity Biotech Recent Development
11.15 Sekisui Diagnostics
11.15.1 Sekisui Diagnostics Company Detail
11.15.2 Sekisui Diagnostics Business Overview
11.15.3 Sekisui Diagnostics Point of Care Diagnostic and Testing Introduction
11.15.4 Sekisui Diagnostics Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.15.5 Sekisui Diagnostics Recent Development
11.16 Orasure Technologies
11.16.1 Orasure Technologies Company Detail
11.16.2 Orasure Technologies Business Overview
11.16.3 Orasure Technologies Point of Care Diagnostic and Testing Introduction
11.16.4 Orasure Technologies Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.16.5 Orasure Technologies Recent Development
11.17 Nipro
11.17.1 Nipro Company Detail
11.17.2 Nipro Business Overview
11.17.3 Nipro Point of Care Diagnostic and Testing Introduction
11.17.4 Nipro Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.17.5 Nipro Recent Development
11.18 Spectral Medical
11.18.1 Spectral Medical Company Detail
11.18.2 Spectral Medical Business Overview
11.18.3 Spectral Medical Point of Care Diagnostic and Testing Introduction
11.18.4 Spectral Medical Revenue in Point of Care Diagnostic and Testing Business (2018-2023)
11.18.5 Spectral Medical Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Point of Care Diagnostic and Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Device
Table 3. Key Players of Consumables
Table 4. Key Players of Others
Table 5. Global Point of Care Diagnostic and Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Point of Care Diagnostic and Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Point of Care Diagnostic and Testing Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Point of Care Diagnostic and Testing Market Share by Region (2018-2023)
Table 9. Global Point of Care Diagnostic and Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Point of Care Diagnostic and Testing Market Share by Region (2024-2029)
Table 11. Point of Care Diagnostic and Testing Market Trends
Table 12. Point of Care Diagnostic and Testing Market Drivers
Table 13. Point of Care Diagnostic and Testing Market Challenges
Table 14. Point of Care Diagnostic and Testing Market Restraints
Table 15. Global Point of Care Diagnostic and Testing Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Point of Care Diagnostic and Testing Market Share by Players (2018-2023)
Table 17. Global Top Point of Care Diagnostic and Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Diagnostic and Testing as of 2022)
Table 18. Ranking of Global Top Point of Care Diagnostic and Testing Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Point of Care Diagnostic and Testing Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Point of Care Diagnostic and Testing Product Solution and Service
Table 22. Date of Enter into Point of Care Diagnostic and Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Point of Care Diagnostic and Testing Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Point of Care Diagnostic and Testing Revenue Market Share by Type (2018-2023)
Table 26. Global Point of Care Diagnostic and Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Point of Care Diagnostic and Testing Revenue Market Share by Type (2024-2029)
Table 28. Global Point of Care Diagnostic and Testing Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Point of Care Diagnostic and Testing Revenue Market Share by Application (2018-2023)
Table 30. Global Point of Care Diagnostic and Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Point of Care Diagnostic and Testing Revenue Market Share by Application (2024-2029)
Table 32. North America Point of Care Diagnostic and Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Point of Care Diagnostic and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Point of Care Diagnostic and Testing Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Point of Care Diagnostic and Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Point of Care Diagnostic and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Point of Care Diagnostic and Testing Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Point of Care Diagnostic and Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Point of Care Diagnostic and Testing Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Point of Care Diagnostic and Testing Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Point of Care Diagnostic and Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Point of Care Diagnostic and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Point of Care Diagnostic and Testing Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Point of Care Diagnostic and Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Point of Care Diagnostic and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Point of Care Diagnostic and Testing Market Size by Country (2024-2029) & (US$ Million)
Table 47. F. Hoffmann-La Roche Company Detail
Table 48. F. Hoffmann-La Roche Business Overview
Table 49. F. Hoffmann-La Roche Point of Care Diagnostic and Testing Product
Table 50. F. Hoffmann-La Roche Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 51. F. Hoffmann-La Roche Recent Development
Table 52. Qiagen Company Detail
Table 53. Qiagen Business Overview
Table 54. Qiagen Point of Care Diagnostic and Testing Product
Table 55. Qiagen Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 56. Qiagen Recent Development
Table 57. Danaher Company Detail
Table 58. Danaher Business Overview
Table 59. Danaher Point of Care Diagnostic and Testing Product
Table 60. Danaher Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 61. Danaher Recent Development
Table 62. Becton Dickinson and Company Company Detail
Table 63. Becton Dickinson and Company Business Overview
Table 64. Becton Dickinson and Company Point of Care Diagnostic and Testing Product
Table 65. Becton Dickinson and Company Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 66. Becton Dickinson and Company Recent Development
Table 67. Biomerieux Company Detail
Table 68. Biomerieux Business Overview
Table 69. Biomerieux Point of Care Diagnostic and Testing Product
Table 70. Biomerieux Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 71. Biomerieux Recent Development
Table 72. Siemens Healthcare Company Detail
Table 73. Siemens Healthcare Business Overview
Table 74. Siemens Healthcare Point of Care Diagnostic and Testing Product
Table 75. Siemens Healthcare Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 76. Siemens Healthcare Recent Development
Table 77. Zoetis Company Detail
Table 78. Zoetis Business Overview
Table 79. Zoetis Point of Care Diagnostic and Testing Product
Table 80. Zoetis Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 81. Zoetis Recent Development
Table 82. Abbott Company Detail
Table 83. Abbott Business Overview
Table 84. Abbott Point of Care Diagnostic and Testing Product
Table 85. Abbott Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 86. Abbott Recent Development
Table 87. Bayer Company Detail
Table 88. Bayer Business Overview
Table 89. Bayer Point of Care Diagnostic and Testing Product
Table 90. Bayer Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. Johnson and Johnson Company Detail
Table 93. Johnson and Johnson Business Overview
Table 94. Johnson and Johnson Point of Care Diagnostic and Testing Product
Table 95. Johnson and Johnson Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 96. Johnson and Johnson Recent Development
Table 97. Nova Biomedical Company Detail
Table 98. Nova Biomedical Business Overview
Table 99. Nova Biomedical Point of Care Diagnostic and Testing Product
Table 100. Nova Biomedical Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 101. Nova Biomedical Recent Development
Table 102. Trividia Health Company Detail
Table 103. Trividia Health Business Overview
Table 104. Trividia Health Point of Care Diagnostic and Testing Product
Table 105. Trividia Health Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 106. Trividia Health Recent Development
Table 107. Quidel Corporation Company Detail
Table 108. Quidel Corporation Business Overview
Table 109. Quidel Corporation Point of Care Diagnostic and Testing Product
Table 110. Quidel Corporation Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 111. Quidel Corporation Recent Development
Table 112. Trinity Biotech Company Detail
Table 113. Trinity Biotech Business Overview
Table 114. Trinity Biotech Point of Care Diagnostic and Testing Product
Table 115. Trinity Biotech Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 116. Trinity Biotech Recent Development
Table 117. Sekisui Diagnostics Company Detail
Table 118. Sekisui Diagnostics Business Overview
Table 119. Sekisui Diagnostics Point of Care Diagnostic and Testing Product
Table 120. Sekisui Diagnostics Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 121. Sekisui Diagnostics Recent Development
Table 122. Orasure Technologies Company Detail
Table 123. Orasure Technologies Business Overview
Table 124. Orasure Technologies Point of Care Diagnostic and Testing Product
Table 125. Orasure Technologies Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 126. Orasure Technologies Recent Development
Table 127. Nipro Company Detail
Table 128. Nipro Business Overview
Table 129. Nipro Point of Care Diagnostic and Testing Product
Table 130. Nipro Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 131. Nipro Recent Development
Table 132. Spectral Medical Company Detail
Table 133. Spectral Medical Business Overview
Table 134. Spectral Medical Point of Care Diagnostic and Testing Product
Table 135. Spectral Medical Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 136. Spectral Medical Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
Table 1. Global Point of Care Diagnostic and Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Device
Table 3. Key Players of Consumables
Table 4. Key Players of Others
Table 5. Global Point of Care Diagnostic and Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Point of Care Diagnostic and Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Point of Care Diagnostic and Testing Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Point of Care Diagnostic and Testing Market Share by Region (2018-2023)
Table 9. Global Point of Care Diagnostic and Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Point of Care Diagnostic and Testing Market Share by Region (2024-2029)
Table 11. Point of Care Diagnostic and Testing Market Trends
Table 12. Point of Care Diagnostic and Testing Market Drivers
Table 13. Point of Care Diagnostic and Testing Market Challenges
Table 14. Point of Care Diagnostic and Testing Market Restraints
Table 15. Global Point of Care Diagnostic and Testing Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Point of Care Diagnostic and Testing Market Share by Players (2018-2023)
Table 17. Global Top Point of Care Diagnostic and Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Diagnostic and Testing as of 2022)
Table 18. Ranking of Global Top Point of Care Diagnostic and Testing Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Point of Care Diagnostic and Testing Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Point of Care Diagnostic and Testing Product Solution and Service
Table 22. Date of Enter into Point of Care Diagnostic and Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Point of Care Diagnostic and Testing Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Point of Care Diagnostic and Testing Revenue Market Share by Type (2018-2023)
Table 26. Global Point of Care Diagnostic and Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Point of Care Diagnostic and Testing Revenue Market Share by Type (2024-2029)
Table 28. Global Point of Care Diagnostic and Testing Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Point of Care Diagnostic and Testing Revenue Market Share by Application (2018-2023)
Table 30. Global Point of Care Diagnostic and Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Point of Care Diagnostic and Testing Revenue Market Share by Application (2024-2029)
Table 32. North America Point of Care Diagnostic and Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Point of Care Diagnostic and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Point of Care Diagnostic and Testing Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Point of Care Diagnostic and Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Point of Care Diagnostic and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Point of Care Diagnostic and Testing Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Point of Care Diagnostic and Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Point of Care Diagnostic and Testing Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Point of Care Diagnostic and Testing Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Point of Care Diagnostic and Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Point of Care Diagnostic and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Point of Care Diagnostic and Testing Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Point of Care Diagnostic and Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Point of Care Diagnostic and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Point of Care Diagnostic and Testing Market Size by Country (2024-2029) & (US$ Million)
Table 47. F. Hoffmann-La Roche Company Detail
Table 48. F. Hoffmann-La Roche Business Overview
Table 49. F. Hoffmann-La Roche Point of Care Diagnostic and Testing Product
Table 50. F. Hoffmann-La Roche Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 51. F. Hoffmann-La Roche Recent Development
Table 52. Qiagen Company Detail
Table 53. Qiagen Business Overview
Table 54. Qiagen Point of Care Diagnostic and Testing Product
Table 55. Qiagen Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 56. Qiagen Recent Development
Table 57. Danaher Company Detail
Table 58. Danaher Business Overview
Table 59. Danaher Point of Care Diagnostic and Testing Product
Table 60. Danaher Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 61. Danaher Recent Development
Table 62. Becton Dickinson and Company Company Detail
Table 63. Becton Dickinson and Company Business Overview
Table 64. Becton Dickinson and Company Point of Care Diagnostic and Testing Product
Table 65. Becton Dickinson and Company Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 66. Becton Dickinson and Company Recent Development
Table 67. Biomerieux Company Detail
Table 68. Biomerieux Business Overview
Table 69. Biomerieux Point of Care Diagnostic and Testing Product
Table 70. Biomerieux Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 71. Biomerieux Recent Development
Table 72. Siemens Healthcare Company Detail
Table 73. Siemens Healthcare Business Overview
Table 74. Siemens Healthcare Point of Care Diagnostic and Testing Product
Table 75. Siemens Healthcare Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 76. Siemens Healthcare Recent Development
Table 77. Zoetis Company Detail
Table 78. Zoetis Business Overview
Table 79. Zoetis Point of Care Diagnostic and Testing Product
Table 80. Zoetis Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 81. Zoetis Recent Development
Table 82. Abbott Company Detail
Table 83. Abbott Business Overview
Table 84. Abbott Point of Care Diagnostic and Testing Product
Table 85. Abbott Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 86. Abbott Recent Development
Table 87. Bayer Company Detail
Table 88. Bayer Business Overview
Table 89. Bayer Point of Care Diagnostic and Testing Product
Table 90. Bayer Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. Johnson and Johnson Company Detail
Table 93. Johnson and Johnson Business Overview
Table 94. Johnson and Johnson Point of Care Diagnostic and Testing Product
Table 95. Johnson and Johnson Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 96. Johnson and Johnson Recent Development
Table 97. Nova Biomedical Company Detail
Table 98. Nova Biomedical Business Overview
Table 99. Nova Biomedical Point of Care Diagnostic and Testing Product
Table 100. Nova Biomedical Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 101. Nova Biomedical Recent Development
Table 102. Trividia Health Company Detail
Table 103. Trividia Health Business Overview
Table 104. Trividia Health Point of Care Diagnostic and Testing Product
Table 105. Trividia Health Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 106. Trividia Health Recent Development
Table 107. Quidel Corporation Company Detail
Table 108. Quidel Corporation Business Overview
Table 109. Quidel Corporation Point of Care Diagnostic and Testing Product
Table 110. Quidel Corporation Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 111. Quidel Corporation Recent Development
Table 112. Trinity Biotech Company Detail
Table 113. Trinity Biotech Business Overview
Table 114. Trinity Biotech Point of Care Diagnostic and Testing Product
Table 115. Trinity Biotech Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 116. Trinity Biotech Recent Development
Table 117. Sekisui Diagnostics Company Detail
Table 118. Sekisui Diagnostics Business Overview
Table 119. Sekisui Diagnostics Point of Care Diagnostic and Testing Product
Table 120. Sekisui Diagnostics Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 121. Sekisui Diagnostics Recent Development
Table 122. Orasure Technologies Company Detail
Table 123. Orasure Technologies Business Overview
Table 124. Orasure Technologies Point of Care Diagnostic and Testing Product
Table 125. Orasure Technologies Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 126. Orasure Technologies Recent Development
Table 127. Nipro Company Detail
Table 128. Nipro Business Overview
Table 129. Nipro Point of Care Diagnostic and Testing Product
Table 130. Nipro Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 131. Nipro Recent Development
Table 132. Spectral Medical Company Detail
Table 133. Spectral Medical Business Overview
Table 134. Spectral Medical Point of Care Diagnostic and Testing Product
Table 135. Spectral Medical Revenue in Point of Care Diagnostic and Testing Business (2018-2023) & (US$ Million)
Table 136. Spectral Medical Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Point of Care Diagnostic and Testing Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Point of Care Diagnostic and Testing Market Share by Type: 2022 VS 2029
Figure 3. Device Features
Figure 4. Consumables Features
Figure 5. Others Features
Figure 6. Global Point of Care Diagnostic and Testing Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Point of Care Diagnostic and Testing Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Home Case Studies
Figure 11. Others Case Studies
Figure 12. Point of Care Diagnostic and Testing Report Years Considered
Figure 13. Global Point of Care Diagnostic and Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Point of Care Diagnostic and Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Point of Care Diagnostic and Testing Market Share by Region: 2022 VS 2029
Figure 16. Global Point of Care Diagnostic and Testing Market Share by Players in 2022
Figure 17. Global Top Point of Care Diagnostic and Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Diagnostic and Testing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Point of Care Diagnostic and Testing Revenue in 2022
Figure 19. North America Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Point of Care Diagnostic and Testing Market Share by Country (2018-2029)
Figure 21. United States Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Point of Care Diagnostic and Testing Market Share by Country (2018-2029)
Figure 25. Germany Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Point of Care Diagnostic and Testing Market Share by Region (2018-2029)
Figure 33. China Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Point of Care Diagnostic and Testing Market Share by Country (2018-2029)
Figure 41. Mexico Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Point of Care Diagnostic and Testing Market Share by Country (2018-2029)
Figure 45. Turkey Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 48. Qiagen Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 49. Danaher Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 50. Becton Dickinson and Company Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 51. Biomerieux Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 52. Siemens Healthcare Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 53. Zoetis Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 54. Abbott Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 55. Bayer Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 56. Johnson and Johnson Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 57. Nova Biomedical Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 58. Trividia Health Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 59. Quidel Corporation Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 60. Trinity Biotech Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 61. Sekisui Diagnostics Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 62. Orasure Technologies Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 63. Nipro Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 64. Spectral Medical Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Global Point of Care Diagnostic and Testing Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Point of Care Diagnostic and Testing Market Share by Type: 2022 VS 2029
Figure 3. Device Features
Figure 4. Consumables Features
Figure 5. Others Features
Figure 6. Global Point of Care Diagnostic and Testing Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Point of Care Diagnostic and Testing Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Home Case Studies
Figure 11. Others Case Studies
Figure 12. Point of Care Diagnostic and Testing Report Years Considered
Figure 13. Global Point of Care Diagnostic and Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Point of Care Diagnostic and Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Point of Care Diagnostic and Testing Market Share by Region: 2022 VS 2029
Figure 16. Global Point of Care Diagnostic and Testing Market Share by Players in 2022
Figure 17. Global Top Point of Care Diagnostic and Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Diagnostic and Testing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Point of Care Diagnostic and Testing Revenue in 2022
Figure 19. North America Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Point of Care Diagnostic and Testing Market Share by Country (2018-2029)
Figure 21. United States Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Point of Care Diagnostic and Testing Market Share by Country (2018-2029)
Figure 25. Germany Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Point of Care Diagnostic and Testing Market Share by Region (2018-2029)
Figure 33. China Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Point of Care Diagnostic and Testing Market Share by Country (2018-2029)
Figure 41. Mexico Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Point of Care Diagnostic and Testing Market Share by Country (2018-2029)
Figure 45. Turkey Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Point of Care Diagnostic and Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 48. Qiagen Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 49. Danaher Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 50. Becton Dickinson and Company Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 51. Biomerieux Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 52. Siemens Healthcare Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 53. Zoetis Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 54. Abbott Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 55. Bayer Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 56. Johnson and Johnson Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 57. Nova Biomedical Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 58. Trividia Health Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 59. Quidel Corporation Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 60. Trinity Biotech Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 61. Sekisui Diagnostics Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 62. Orasure Technologies Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 63. Nipro Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 64. Spectral Medical Revenue Growth Rate in Point of Care Diagnostic and Testing Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
